.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cancer survivors often struggle with long-term nutritional issues after completing intensive treatment cycles. Researchers recently conducted a pilot feasibility study to determine if a mobile nutrition app cancer survivors use could effectively bridge the gap in dietary self-management. The study, conducted at a tertiary center in Korea, assessed 24 participants over four weeks to evaluate engagement and clinical outcomes.
Participants showed high engagement, averaging 2.3 sessions daily with a median adherence rate exceeding 85%. Consequently, the study observed a significant improvement in the "Moderation" domain of the Nutrition Quotient for Adults. This indicates that digital monitoring encourages survivors to better manage calorie-dense and processed food intake. Furthermore, users reported a significant reduction in appetite loss, highlighting the app's role in symptom management.
The pilot study also explored the correlation between app engagement and quality of life (QoL). Notably, higher engagement levels directly corresponded with improved dietary moderation and reduced appetite loss. Moreover, subgroup analyses suggested that the mobile nutrition app cancer survivors utilized had the most profound impact on participants aged 60 and older. This finding suggests that mHealth tools are accessible and beneficial across different age demographics.
Although the sample size was small, the high retention rate of 88.9% demonstrates the feasibility of digital nutrition interventions. These preliminary results pave the way for larger randomized controlled trials to confirm long-term efficacy. For clinicians, these tools offer a scalable method to provide continuous supportive care beyond the hospital setting.
Yes. In this study, survivors using the mobile nutrition app reported a significant decrease in appetite loss and a modest increase in global health status.
Evidence suggests they are. In fact, participants aged 60 and older in this study showed greater improvements in dietary moderation than their younger counterparts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A pilot study explores how a mobile nutrition app improves dietary behavior, moderation, and appetite loss in cancer survivors with high user engagement....
5 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
